MM-897: Efficacy of Isatuximab Plus Dexamethasone Versus No Isatuximab-Based Treatments in Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis

Víctor CastilloLuis E. Cueva-CañolaAlex TorresA. PérezAlejandro MuñózAbraham Zenteno-AguilarKaroly P Zuñiga-MontañoCarlos Espinosa-TemaxteSergio Morales AcostaWagner Rios-Acosta2026-03-222026-03-22202510.1016/s2152-2650(25)02654-0https://doi.org/10.1016/s2152-2650(25)02654-0https://andeanlibrary.org/handle/123456789/85856Citaciones: 1enMedicineMeta-analysisDexamethasoneMultiple myelomaInternal medicineMM-897: Efficacy of Isatuximab Plus Dexamethasone Versus No Isatuximab-Based Treatments in Refractory Multiple Myeloma: A Systematic Review and Meta-Analysisreview